-
Mashup Score: 0Adult Immunization - 10 day(s) ago
IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data. IDWeek2024: The nanoparticle influenza vaccine and combination flu-Covid-19 shot produced immunogenicity comparable to or higher than comparator vaccines. V116 (CAPVAXIVE™) covers the serotypes responsible for approximately 84% of invasive pneumococcal disease cases in adults aged 50 years and older. Data on adults aged 60 years and older
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from AM Diabetes and Endocrinology Center - 13 day(s) ago
In this program, a panel of experts in the management of diabetes educate healthcare providers on teplizumab’s role in delaying type 1 diabetes stage progression through early intervention. It covers disease staging, screening recommendations, eligibility processes, teplizumab’s mechanism of action, and the navigation of the 14-day infusion regimen. By facilitating timely teplizumab access, the program aims to identify at-risk patients, reduce diabetic ketoacidosis, mitigate disease burdens, and improve quality of life.
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet-
Breakthroughs in T1D early intervention are here! 🩺 Our Institutional Insights video series explores teplizumab and cutting-edge strategies. Don't miss out; watch now and empower your patients! https://t.co/SbTRQGzF3S #T1D #HealthCare https://t.co/gqdQSyCuVE
-
-
Mashup Score: 0
Panelists discuss how KNDy neurons and NK receptors contribute to vasomotor symptoms (VMS) in menopause and explore emerging nonhormonal therapies, including fezolinetant and elinzanetant, for effective symptom management.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet-
Watch Now: VMS and Menopause: KNDy Neurons, NK Receptors, and Practical Insights. Learn from top experts in this 9-part video series. https://t.co/fo0cNSJL86 https://t.co/41hPugvPz6
-
-
Mashup Score: 0Dermatology - 18 day(s) ago
Among adolescents and adults with moderate-to-severe AD, more than 80% achieved sustained disease control, the majority not requiring topical or systemic rescue medication. Roflumilast cream 0.15% was associated with consistent and meaningful improvements in AD clearance and itch reduction, according to new data. Delgocitinib specifically inhibits activation of JAK-STAT signaling in chronic hand eczema and would be an option for people unable to use topical corticosteroids. Your daily dose of the
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet-
Discover the latest breakthroughs in Atopic Dermatitis treatment! Stay informed on FDA-approved drugs, patient perspectives, and best practices. Explore our comprehensive resource center today. https://t.co/fkA3PFItgG #atopicdermatitis #treatment #healthcare https://t.co/Qs3Abu6UiE
-
-
Mashup Score: 0Geriatric Diabetes Care: Optimizing Type 2 Diabetes Management Insights from Dr. Javier Morales - 19 day(s) ago
Medha Munshi, MD, and Javier Morales, MD, FACP, FACE, emphasize the significance of personalized diabetes management, emphasizing age and other patient-specific factors as crucial considerations for optimizing care.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet-
Are you struggling to treat older patients with type 2 diabetes? Discover expert-led strategies for optimal management. Learn about tailored treatment plans, medication optimization, and more. Watch now to improve patient outcomes. Start now: https://t.co/2FkpmIUuLp https://t.co/XT6nrVycYo
-
-
Mashup Score: 0Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from Albany Medical Center - 21 day(s) ago
In this program, a panel of medical experts from Albany Medical Center in the management of diabetes educate healthcare providers on teplizumab’s role in delaying type 1 diabetes stage progression through early intervention. It covers disease staging, screening recommendations, eligibility processes, teplizumab’s mechanism of action, and the navigation of the 14-day infusion regimen. By facilitating timely teplizumab access, the program aims to identify at-risk patients, reduce diabetic ketoacidosis, mitigate disease burdens, and improve quality of life.
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet-
Delve into cutting-edge strategies aimed at delaying the progression of type 1 diabetes (T1D). These videos provide invaluable insights into the role of teplizumab in T1D management, disease staging, screening recommendations, and more. https://t.co/dTOJxsCebh https://t.co/4UriP0rXlA
-
-
Mashup Score: 0Geriatric Diabetes Care: Optimizing Type 2 Diabetes Management Insights from Dr. Conan Tu - 21 day(s) ago
Medha Munshi, MD, and Conan Tu, MD, MBA, DACD, BC-ADM, present patient cases, review clinical trial data, and provide comprehensive insights on the treatment of older adult patients with type 2 diabetes.
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet-
Struggling to manage type 2 diabetes in older adults? Discover the latest strategies, best practices, and real-world case studies. Learn from the experts and improve patient outcomes today! https://t.co/Lpd8w2uS2K https://t.co/BKfGzXi7rS
-
-
Mashup Score: 0Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from UC San Diego Health - 25 day(s) ago
A panel of experts on the management of type 1 diabetes have a detailed discussion on treatment practices, focusing on staging, screening, the infusion process of a novel treatment to delay the onset of this condition.
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet-
Stop T1D in its tracks! UC San Diego Health experts reveal new strategies in part III of our Institutional Insights video series. https://t.co/iUm9OqUkjB #T1D #DiabetesAwareness https://t.co/ln9641FNOM
-
-
Mashup Score: 0Geriatric Diabetes Care: Optimizing Type 2 Diabetes Management Insights from Dr. John Anderson - 28 day(s) ago
Medha Munshi, MD, and John E Anderson, MD,discuss comprehensive strategies for personalized diabetes management in older adults, covering case studies, treatment adjustments, combination therapies, and deprescribing, with a focus on tailoring care for effective geriatric diabetes care.
Source: www.patientcareonline.comCategories: General Medicine News, General Journals & SocietTweet-
Master geriatric diabetes care! Optimize diabetes management in older adults. Learn expert strategies for personalized treatment, medication adjustments, and patient care. Improve patient outcomes today. Watch Now: https://t.co/uKZpuwSb5O https://t.co/bBslAelwV0
-
-
Mashup Score: 0Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from AM Diabetes and Endocrinology Center - 1 month(s) ago
In this program, a panel of experts in the management of diabetes educate healthcare providers on teplizumab’s role in delaying type 1 diabetes stage progression through early intervention. It covers disease staging, screening recommendations, eligibility processes, teplizumab’s mechanism of action, and the navigation of the 14-day infusion regimen. By facilitating timely teplizumab access, the program aims to identify at-risk patients, reduce diabetic ketoacidosis, mitigate disease burdens, and improve quality of life.
Source: www.patientcareonline.comCategories: General Medicine News, PayerTweet-
Breakthroughs in T1D early intervention are here! 🩺 Our Institutional Insights video series explores teplizumab and cutting-edge strategies. Don't miss out; watch now and empower your patients! https://t.co/SbTRQGzF3S #T1D #HealthCare https://t.co/gqdQSyCuVE
-
Empower your patients with the latest information on adult immunization. Discover breakthroughs in RSV, mpox, and influenza vaccines. Our comprehensive resource center provides the insights you need to deliver optimal care. Visit our resource center now! https://t.co/J2nmIRh3UI https://t.co/AXYfniDLhr